QSPR models for the prediction of apparent volume of distribution

被引:46
作者
Ghafourian, Taravat [1 ]
Barzegar-Jalali, Mohammad
Dastmalchi, Siavoush
Khavari-Khorasani, Tina
Hakimiha, Nasim
Nokhodchi, Ali
机构
[1] Tabriz Univ Med Sci, Drug Design & Chemomet Lab, Drug Appl Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Sch Pharm, Tabriz, Iran
[3] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
[4] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran
关键词
volume of distribution; QSPR; pharmacokinetics; V-d; in silico; prediction;
D O I
10.1016/j.ijpharm.2006.03.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An estimate of volume of distribution (V-d) is of paramount importance both in drug choice as well as maintenance and loading dose calculations in therapeutics. It can also be used in the prediction of drug biological half life. This study employs quantitative structure-pharmacokinetic relationship (QSPR) techniques for the prediction of volume of distribution. Values of Vd for 129 drugs were collated from the literature. Structural descriptors consisted of partitioning, quantum mechanical, molecular mechanical, and connectivity parameters calculated by specialized software and pK(a) values obtained from ACD labs/log D database. Genetic algorithm and stepwise regression analyses were used for variable selection and model development. Models were validated using a leave-many-out procedure. QSPR analyses resulted in a number of significant models for acidic and basic drugs separately, and for all the drugs. Validation studies showed that mean fold error of predictions for the selected models were between 1.79 and 2.17. Although separate QSPR models for acids and bases resulted in lower prediction errors than models for all the drugs, the external validation study showed a limited applicability for the equation obtained for acids. Therefore, the universal model that requires only calculated structural descriptors was recommended. The QSPR model is able to predict the volume of distribution of drugs belonging to different chemical classes with a prediction error similar to that of the other more complicated prediction methods including the commonly practiced interspecies scaling. The structural descriptors in the model can be interpreted based on the known mechanisms of distribution and the molecular structures of the drugs. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:82 / 97
页数:16
相关论文
共 38 条
[1]  
Abraham MH, 1999, PESTIC SCI, V55, P78, DOI 10.1002/(SICI)1096-9063(199901)55:1<78::AID-PS853>3.0.CO
[2]  
2-7
[3]   PHARMACOKINETICS OF NALIDIXIC-ACID IN OLD AND YOUNG VOLUNTEERS [J].
BARBEAU, G ;
BELANGER, PM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (10) :490-496
[4]   Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat [J].
Blakey, GE ;
Nestorov, IA ;
Arundel, PA ;
Aarons, LJ ;
Rowland, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (03) :277-312
[5]  
CUTLER RE, 1978, CLIN PHARMACOL THER, V24, P333
[6]  
Davis AM, 2000, DRUG METAB DISPOS, V28, P103
[7]   Hydrogen bonding parameters for QSAR: Comparison of indicator variables, hydrogen bond counts, molecular orbital and other parameters [J].
Dearden, JC ;
Ghafourian, T .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (02) :231-235
[8]   HEPATIC DRUG-METABOLISM AND AGING [J].
DURNAS, C ;
LOI, CM ;
CUSACK, BJ .
CLINICAL PHARMACOKINETICS, 1990, 19 (05) :359-389
[9]   A simple model for the prediction of blood-brain partitioning [J].
Feher, M ;
Sourial, E ;
Schmidt, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 201 (02) :239-247
[10]   DOXAZOSIN - AN UPDATE OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS IN HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA (VOL 49, PG 295, 1995) [J].
FULTON, B ;
WAGSTAFF, AJ ;
SOROKIN, EM .
DRUGS, 1995, 50 (03) :559-559